# US 2004/0062773 A1 · Compositions for the delivery of antigens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0062773 A1
- Document ID: US20040062773A1
- Status: Published application
- Kind: A1
- Application number: 10/600,386
- Filed: 2003-06-19
- Published: 2004-04-01
- Earliest claimed: 1993-04-22
- Assignees: Emisphere Technologies, Inc.
- Inventors: Noemi B. Santiago; Susan Haas; Andrea Leone-Bay; Sam J. Milstein; Evgueni Barantsevitch
- Web page: https://patentgrep.com/patent/US20040062773A1

## CPC

- A61K 31/727: Heparin; Heparan
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 31/16: Amides, e.g. hydroxamic acids
- A61K 38/212: {IFN-alpha}
- A61K 38/23: Calcitonins
- A61K 38/25: Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- A61K 38/27: Growth hormone [GH], i.e. somatotropin
- A61K 39/12: Viral antigens
- A61K 39/39: characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- C07C 229/42: with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
- C07C 233/55: having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
- C07C 233/63: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C 233/87: of a carbon skeleton containing six-membered aromatic rings
- C07C 235/38: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 235/64: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 235/84: with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C 237/22: having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated (peptides C07K)
- A61K 2039/5252: {inactivated (killed)}
- A61K 2039/542: {oral/gastrointestinal}
- A61K 2039/55544: {Bacterial toxins}
- A61K 2039/55555: {Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers}
- C07C 2601/02: with a three-membered ring
- C07C 2601/14: The ring being saturated
- C07C 2601/18: with a ring being at least seven-membered
- C12N 2720/10034: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C12N 2720/10061: Methods of inactivation or attenuation
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to compositions and methods for orally delivering antigens. The antigen and an adjuvant are combined with an acylated amino acid or polyamino acid and, a sulfonated amino acids or polyamino acid, or a salt of the foregoing.

## Claims

### Claim 1

A composition comprising:
(a) an antigen;
(b) an adjuvant;
(c) at least one carrier comprising a member selected from the groups consisting of:
(i) an acylated amino acid or a salt thereof;
(ii) a poly amino acid comprising at least one acylated amino acid or a salt thereof;
(iii) a sulfonated amino acid or a salt thereof;
(iv) a poly amino acid comprising at least one sulfonated amino acid or a salt thereof; or
(v) any combination thereof.

### Claim 2 (depends on 1)

A composition as defined in claim 1, comprising a mixture.

### Claim 3 (depends on 1)

A composition as defined in claim 1, comprising a microsphere.

### Claim 4 (depends on 1)

A composition as defined in claim 1, wherein said antigen comprises a peptide.

### Claim 5 (depends on 1)

A composition as defined in claim 1, wherein said adjuvant comprises a mucosal adjuvant.

### Claim 6 (depends on 1)

A composition as defined in claim 1, wherein said carrier comprises an acylated amino acid or a salt thereof,

### Claim 7 (depends on 1)

A composition as defined in claim 1, wherein said carrier comprises a poly amino acid comprising at least one acylated amino acid or a salt thereof.

### Claim 8 (depends on 1)

A composition as defined in claim 1, wherein said carrier comprises a sulfonated amino acid or a salt thereof.

### Claim 9 (depends on 1)

A composition as defined in claim 1, wherein said carrier comprises a poly amino acid comprising at least one sulfonated amino acid or a salt thereof.

### Claim 10 (depends on 1)

A composition as defined in claim 1, wherein said carrier is selected from the group consisting of, N-cyclohexanoyl arginine; a mixture of N-cyclohexanoyltyrosine and N-cyclohexanoylleucine; a mixture of N-phenylsulfonylvaline, N-phenylsulfonylleucine, N-phenylsulfonylphenylalanine, N-phenylsulfonyllysine, and N-phenylsulfonylarginine; and a mixture of N-benzoylvaline, N-benzoylleucine, N-benzoylphenyl-alanine, N-benzoyllysine, and N-benzoylarginine.

### Claim 11

A composition comprising:
(a) ovalbumin;
(b) cholera toxin; and
(c) at least one carrier comprising a member selected from the groups consisting of:
(i) an acylated amino acid or a salt thereof;
(ii) a poly amino acid comprising at least one acylated amino acid or a salt thereof;
(iii) a sulfonated amino acid or a salt thereof;
(iv) a poly amino acid comprising at least one sulfonated amino acid or a salt thereof; or
(v) any combination thereof.

### Claim 12

A composition comprising:
(a) Infectious Bursal Disease Virus;
(b) cholera toxin;
(c) cholera toxin β-subunit; and
(d) at least one carrier comprising a member selected from the groups consisting of:
(i) an acylated amino acid or a salt thereof;
(ii) a poly amino acid comprising at least one acylated amino acid or a salt thereof;
(iii) a sulfonated amino acid or a salt thereof;
(iv) a poly amino acid comprising at least one sulfonated amino acid or a salt thereof; or
(v) any combination thereof.

### Claim 13 (depends on 12)

A composition as defined in claim 12, comprising a microsphere.

### Claim 14 (depends on 1)

A dosage unit form comprising
(A) a composition according to claim 1; and
(B)
(a) an excipient,
(b) a diluent,
(c) a disintegrant,
(d) a lubricant,
(e) a plasticizer,
(f) a colorant,
(g) a dosing vehicle, or
(h) any combination thereof.

### Claim 15 (depends on 14)

A dosage unit form according to claim 14 comprising a tablet, a capsule, or a liquid.

### Claim 16 (depends on 1)

A method for administering an antigen to an animal, said method comprising orally administering a composition as defined in claim 1.

### Claim 17 (depends on 12)

A method for immunizing chickens, said method comprising orally administering a composition as defined in claim 12.

### Claim 18 (depends on 1)

A method for preparing a composition as defined in claim 1, said method comprising mixing an antigen, an adjuvant, and a carrier comprising a member selected from the group consisting of:
(i) an acylated amino acid or a salt thereof;
(ii) a poly amino acid comprising at least one acylated amino acid or a salt thereof;
(iii) a sulfonated amino acid or a salt thereof;
(iv) a poly amino acid comprising at least one sulfonated amino acid or a salt thereof; or
(v) any combination thereof.

### Claim 19

A method for preparing microspheres, said method comprising:
(A) solubilizing, in a solvent, at least one carrier to provide a carrier solution; and
(B) contacting said carrier solution with an antigen, an adjuvant, and a precipitator solution in which said carrier is insoluble;
wherein said carrier comprises a member selected from the groups consisting of:
(a) an acylated amino acid or a salt thereof;
(b) a poly amino acid comprising at least one acylated amino acid or a salt thereof;
(c) a sulfonated amino acid or a salt thereof;
(d) a poly amino acid comprising at least one sulfonated amino acid or a salt thereof; or
(e) any combination thereof.

### Claim 20 (depends on 19)

A method as defined in claim 19, wherein said carrier solution has a pH within a first range and said precipitator solution has a pH within a second range, said first range being different than said second range.

### Claim 21 (depends on 12)

A composition as defined in claim 12, wherein the carrier comprises a mixture of N-phenylsulfonylvaline, N-phenylsulfonylleucine, N-phenylsulfonylphenylalanine, N-phenyl-sulfonyllysine, and N-phenylsulfonylarginine; and a stabilizer.

### Claim 22 (depends on 21)

A composition as defined in claim 21, wherein said stabilizer comprises sodium 2-cyclohexylbutyrate.
